Decrease of p400 ATPase complex and loss of H2A.Z within the p21 promoter occur in senescent IMR-90 human fibroblasts

Mechanisms of Ageing and Development

Volumn 133, Issue 11-12, 2012, Pages 686-694

  Lee, Kangmoon ^a,b   Lau, Zin Zee ^a   Meredith, Courtney ^a   Park, Jeong Hyeon ^a  

^a MASSEY UNIVERSITY   (New Zealand)

^b Korea Polytechnic University   (South Korea)

Author keywords

H2A.Z; P21; P400; P53; Senescence

Indexed keywords

ADENOSINE TRIPHOSPHATASE; DOXORUBICIN; HISTONE H2AZ; P400 ADENOSINE TRIPHOSPHATASE; PROTEIN P21; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL AGING; CELL DENSITY; CELL STRESS; CELLULAR DISTRIBUTION; CHROMATIN STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FETUS; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOSOME; P21 GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; TRANSCRIPTION INITIATION;

ADENOSINE TRIPHOSPHATASES; APOPTOSIS; BINDING SITES; CELL AGING; CELL LINE; CHROMATIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; DNA HELICASES; DNA-BINDING PROTEINS; FIBROBLASTS; GENES, P53; HISTONES; HUMANS; MICROCOCCAL NUCLEASE; NUCLEOSOMES; PLASMINOGEN ACTIVATOR INHIBITOR 1; REACTIVE OXYGEN SPECIES; TELOMERE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84870742387     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2012.11.001     Document Type: Article

References (55)

1. Acosta J.C., Gil J. Senescence: a new weapon for cancer therapy. Trends in Cell Biology 2012, 22:211-219.
2. Bowman T.A., Wong M.M., Cox L.K., Baldassare J.J., Chrivia J.C. Loss of H2A.Z is not sufficient to determine transcriptional activity of Snf2-related CBP activator protein or p400 complexes. International Journal of Cell Biology 2011, 2011:715642.
3. Brown J.P., Wei W., Sedivy J.M. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 1997, 277:831-834.
4. Busuttil R., Bahar R., Vijg J. Genome dynamics and transcriptional deregulation in aging. Neuroscience 2007, 145:1341-1347.
5. Cai Y., Jin J., Florens L., Swanson S.K., Kusch T., Li B., Workman J.L., Washburn M.P., Conaway R.C., Conaway J.W. The mammalian YL1 protein is a shared subunit of the TRRAP/TIP60 histone acetyltransferase and SRCAP complexes. Journal of Biological Chemistry 2005, 280:13665-13670.
6. Chan H.M., Narita M., Lowe S.W., Livingston D.M. The p400 E1A-associated protein is a novel component of the p53-->p21 senescence pathway. Genes and Development 2005, 19:196-201.
7. Choudhury A.R., Ju Z., Djojosubroto M.W., Schienke A., Lechel A., Schaetzlein S., Jiang H., Stepczynska A., Wang C., Buer J., Lee H.W., von Zglinicki T., Ganser A., Schirmacher P., Nakauchi H., Rudolph K.L. Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation. Nature Genetics 2007, 39:99-105.
8. Dang W., Steffen K.K., Perry R., Dorsey J.A., Johnson F.B., Shilatifard A., Kaeberlein M., Kennedy B.K., Berger S.L. Histone H4 lysine 16 acetylation regulates cellular lifespan. Nature 2009, 459:802-807.
9. Das C., Tyler J.K. Histone exchange and histone modifications during transcription and aging. Biochimica et Biophysica Acta 2012, 1819:332-342.
10. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:9363-9367.
11. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 1993, 75:817-825.
12. Espinosa J.M., Emerson B.M. Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Molecular Cell 2001, 8:57-69.
13. Ferrai C., Munari D., Luraghi P., Pecciarini L., Cangi M.G., Doglioni C., Blasi F., Crippa M.P. A transcription-dependent micrococcal nuclease-resistant fragment of the urokinase-type plasminogen activator promoter interacts with the enhancer. Journal of Biological Chemistry 2007, 282:12537-12546.
14. Feser J., Tyler J. Chromatin structure as a mediator of aging. FEBS Letters 2011, 585:2041-2048.
15. Funayama R., Saito M., Tanobe H., Ishikawa F. Loss of linker histone H1 in cellular senescence. Journal of Cell Biology 2006, 175:869-880.
16. Gartel A.L., Radhakrishnan S.K. Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Research 2005, 65:3980-3985.
17. Gevry N., Chan H.M., Laflamme L., Livingston D.M., Gaudreau L. p21 transcription is regulated by differential localization of histone H2A.Z. Genes and Development 2007, 21:1869-1881.
18. Gevry N., Svotelis A., Larochelle M., Gaudreau L. Nucleosome mapping. Methods in Molecular Biology 2009, 543:281-291.
19. Gorgoulis V.G., Halazonetis T.D. Oncogene-induced senescence: the bright and dark side of the response. Current Opinion in Cell Biology 2010, 22:816-827.
20. Herbig U., Jobling W.A., Chen B.P., Chen D.J., Sedivy J.M. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Molecular Cell 2004, 14:501-513.
21. Huang B., Vassilev L.T. Reduced transcriptional activity in the p53 pathway of senescent cells revealed by the MDM2 antagonist nutlin-3. Aging (Albany NY) 2009, 1:845-854.
22. Jin C., Zang C., Wei G., Cui K., Peng W., Zhao K., Felsenfeld G. H3.3/H2A.Z double variant-containing nucleosomes mark 'nucleosome-free regions' of active promoters and other regulatory regions. Nature Genetics 2009, 41:941-945.
23. Kruse J.P., Gu W. Modes of p53 regulation. Cell 2009, 137:609-622.
24. Kusch T., Florens L., Macdonald W.H., Swanson S.K., Glaser R.L., Yates J.R., Abmayr S.M., Washburn M.P., Workman J.L. Acetylation by Tip60 is required for selective histone variant exchange at DNA lesions. Science 2004, 306:2084-2087.
25. Laptenko O., Beckerman R., Freulich E., Prives C. p53 binding to nucleosomes within the p21 promoter in vivo leads to nucleosome loss and transcriptional activation. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:10385-10390.
26. Laybourn P.J., Kadonaga J.T. Role of nucleosomal cores and histone H1 in regulation of transcription by RNA polymerase II. Science 1991, 254:238-245.
27. Lu P.Y., Levesque N., Kobor M.S. NuA4 and SWR1-C: two chromatin-modifying complexes with overlapping functions and components. Biochemistry and Cell Biology-Biochimie et Biologie Cellulaire 2009, 87:799-815.
28. Lushnikova T., Bouska A., Odvody J., Dupont W.D., Eischen C.M. Aging mice have increased chromosome instability that is exacerbated by elevated Mdm2 expression. Oncogene 2011, 30:4622-4631.
29. Marine J.C., Jochemsen A.G. Mdmx as an essential regulator of p53 activity. Biochemical and Biophysical Research Communications 2005, 331:750-760.
30. Maslov A.Y., Vijg J. Genome instability, cancer and aging. Biochimica et Biophysica Acta 2009, 1790:963-969.
31. Mattera L., Courilleau C., Legube G., Ueda T., Fukunaga R., Chevillard-Briet M., Canitrot Y., Escaffit F., Trouche D. The E1A-associated p400 protein modulates cell fate decisions by the regulation of ROS homeostasis. PLoS Genetics 2010, 6:e1000983.
32. Mattera L., Escaffit F., Pillaire M.J., Selves J., Tyteca S., Hoffmann J.S., Gourraud P.A., Chevillard-Briet M., Cazaux C., Trouche D. The p400/Tip60 ratio is critical for colorectal cancer cell proliferation through DNA damage response pathways. Oncogene 2009, 28:1506-1517.
33. McConnell B.B., Starborg M., Brookes S., Peters G. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Current Biology 1998, 8:351-354.
34. O'Sullivan R.J., Kubicek S., Schreiber S.L., Karlseder J. Reduced histone biosynthesis and chromatin changes arising from a damage signal at telomeres. Nature Structural & Molecular Biology 2010, 17:1218-1225.
35. Park J.H., Magan N. Reverse transcriptase-coupled quantitative real time PCR analysis of cell-free transcription on the chromatin-assembled p21 promoter. PLoS ONE 2011, 6:e23617.
36. Park J.H., Roeder R.G. GAS41 is required for repression of the p53 tumor suppressor pathway during normal cellular proliferation. Molecular and Cellular Biology 2006, 26:4006-4016.
37. Park J.H., Sun X.J., Roeder R.G. The SANT domain of p400 ATPase represses acetyltransferase activity and coactivator function of TIP60 in basal p21 gene expression. Molecular and Cellular Biology 2010, 30:2750-2761.
38. Rodier F., Campisi J., Bhaumik D. Two faces of p53: aging and tumor suppression. Nucleic Acids Research 2007, 35:7475-7484.
39. Rogakou E.P., Sekeri-Pataryas K.E. Histone variants of H2A and H3 families are regulated during in vitro aging in the same manner as during differentiation. Experimental Gerontology 1999, 34:741-754.
40. Ruhl D.D., Jin J., Cai Y., Swanson S., Florens L., Washburn M.P., Conaway R.C., Conaway J.W., Chrivia J.C. Purification of a human SRCAP complex that remodels chromatin by incorporating the histone variant H2A.Z into nucleosomes. Biochemistry 2006, 45:5671-5677.
41. Salminen A., Kaarniranta K. Control of p53 and NF-kappaB signaling by WIP1 and MIF: role in cellular senescence and organismal aging. Cellular Signalling 2011, 23:747-752.
42. Schones D.E., Cui K., Cuddapah S., Roh T.Y., Barski A., Wang Z., Wei G., Zhao K. Dynamic regulation of nucleosome positioning in the human genome. Cell 2008, 132:887-898.
43. Sedivy J.M., Banumathy G., Adams P.D. Aging by epigenetics - a consequence of chromatin damage?. Experimental Cell Research 2008, 314:1909-1917.
44. Tavernarakis N. Protein synthesis and aging: eIF4E and the soma vs. germline distinction. Cell Cycle 2007, 6:1168-1171.
45. Thakar A., Gupta P., Ishibashi T., Finn R., Silva-Moreno B., Uchiyama S., Fukui K., Tomschik M., Ausio J., Zlatanova J. H2A.Z and H3.3 histone variants affect nucleosome structure: biochemical and biophysical studies. Biochemistry 2009, 48:10852-10857.
46. Tyteca S., Vandromme M., Legube G., Chevillard-Briet M., Trouche D. Tip60 and p400 are both required for UV-induced apoptosis but play antagonistic roles in cell cycle progression. EMBO Journal 2006, 25:1680-1689.
47. Valouev A., Johnson S.M., Boyd S.D., Smith C.L., Fire A.Z., Sidow A. Determinants of nucleosome organization in primary human cells. Nature 2011, 474:516-520.
48. Vaziri H., West M.D., Allsopp R.C., Davison T.S., Wu Y.S., Arrowsmith C.H., Poirier G.G., Benchimol S. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. EMBO Journal 1997, 16:6018-6033.
49. Vousden K.H., Prives C. Blinded by the light: the growing complexity of p53. Cell 2009, 137:413-431.
50. Wang G.G., Allis C.D., Chi P. Chromatin remodeling and cancer. Part I: Covalent histone modifications. Trends in Molecular Medicine 2007, 13:363-372.
51. Wang G.G., Allis C.D., Chi P. Chromatin remodeling and cancer. Part II: ATP-dependent chromatin remodeling. Trends in Molecular Medicine 2007, 13:373-380.
52. Webley K., Bond J.A., Jones C.J., Blaydes J.P., Craig A., Hupp T., Wynford-Thomas D. Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage. Molecular and Cellular Biology 2000, 20:2803-2808.
53. Wei W., Hemmer R.M., Sedivy J.M. Role of p14(ARF) in replicative and induced senescence of human fibroblasts. Molecular and Cellular Biology 2001, 21:6748-6757.
54. Xu Y., Sun Y., Jiang X., Ayrapetov M.K., Moskwa P., Yang S., Weinstock D.M., Price B.D. The p400 ATPase regulates nucleosome stability and chromatin ubiquitination during DNA repair. Journal of Cell Biology 2010, 191:31-43.
55. Young A.P., Schlisio S., Minamishima Y.A., Zhang Q., Li L., Grisanzio C., Signoretti S., Kaelin W.G. VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400. Nature Cell Biology 2008, 10:361-369.